New: NCI-funded clinical trial search
Mednet Logo

How would you approach adjuvant radiation therapy for a Merkel cell carcinoma of the cheek in an immunocompromised patient?

For example, in a patient status-post WLE with a close (2.5 mm) deep margin and negative neck node sampling, would clinical (but not pathologic) PNI change your treatment? Would the decision on neck RT be swayed by the immunocompromised status? Any other modifications to your plan due to immunosuppression?
1 Answer
Mednet Member
Radiation Oncology · The University of Oklahoma College of Medicine
Answered on

Merkel cell carcinoma, as previously discussed, is an extremely insidious and deadly malignancy, usually extending beyond what appear to be negative clinical borders. The fact that this patient is immune compromised has probably led to the development of skin malignancies, but otherwise will not play a significant role in the treatment of this case. I would certainly treat the tumor bed and the immediate lymph node drainage area, levels 1,2 and 3 on the ipsilateral neck. Perineural invasion, if seen pathologically, is a good indication for tracking the nerve distribution from the site of the primary malignancy. An MRI is often helpful to determine if the nerve is actually invaded. With gross nerve invasion I will generally track the nerve a...

Join for free or sign in to see the full answer